Home

This website is developed and funded by Gilead Sciences Ltd and intended for healthcare professionals in the United Kingdom. Adverse Event Reporting

Healthcare Professional Portal

Welcome to GileadPro

Bringing forward innovative new treatments is a critical part of our work, but it is not the end of it. We believe in effective collaboration and partnership with healthcare professionals to support them in treating their patients.

Register / Log in to GileadPro

Our Therapy Areas

Gilead is committed to advancing care for people around the world by bringing forward medicines to address unmet medical needs in virology, oncology, invasive fungal disease and inflammation. We do this through internal research and development, as well as through collaborations with academic and industry partners.

Since 1987, Gilead has delivered more than 25 innovative medicines, helping to improve treatment for people living with diseases such as HIV, viral hepatitis, cancer and other conditions.

Cell Therapy

Our technologies deliver individualised treatments for patients with unmet needs.
Learn more

HIV

Our work in HIV continues to span from prevention to treatment to working toward the goal of a cure.
Learn more

Liver Diseases

We are committed to research and innovation, offering treatments for various liver conditions.
Learn more

Oncology

We are creating the future of oncology to help bring more life to people with cancer.
Learn more

February 2026 UKI-UNB-1993

Adverse events should be reported.

For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). For IE, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead to [email protected] or +44(0) 1223 897500 or +353(0) 21 482 5999.